Literature DB >> 23599928

Mechanisms of protein seeding in neurodegenerative diseases.

Lary C Walker1, Marc I Diamond, Karen E Duff, Bradley T Hyman.   

Abstract

Most age-associated neurodegenerative diseases involve the aggregation of specific proteins within the nervous system. In Alzheimer disease, the insidious pathogenic process begins many years before the symptoms emerge, and the lesions that characterize the disease—senile plaques and neurofibrillary tangles—ramify systematically through the brain. We review evidence that the -amyloid and tau proteins, which aggregate to form senile plaques and neurofibrillary tangles, respectively, are induced to misfold and self-assemble by a process of templated conformational change that amplifies a toxic species. Recent data also indicate that the spread of these lesions from one site to another is mediated by the cellular uptake, transport, and release of endogenous seeds formed by the cognate proteins. This simple pathogenic principle suggests that the formation, trafficking, and metabolism of pathogenic protein seeds are promising therapeutic targets for Alzheimer disease and other neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23599928      PMCID: PMC3665718          DOI: 10.1001/jamaneurol.2013.1453

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  32 in total

Review 1.  Neurodegenerative tauopathies.

Authors:  V M Lee; M Goedert; J Q Trojanowski
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

Authors:  T Gómez-Isla; J L Price; D W McKeel; J C Morris; J H Growdon; B T Hyman
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

3.  CaMKII activation in the entorhinal cortex disrupts previously encoded spatial memory.

Authors:  Masahiro Yasuda; Mark R Mayford
Journal:  Neuron       Date:  2006-04-20       Impact factor: 17.173

4.  Exosomes are released by cultured cortical neurones.

Authors:  J Fauré; G Lachenal; M Court; J Hirrlinger; C Chatellard-Causse; B Blot; J Grange; G Schoehn; Y Goldberg; V Boyer; F Kirchhoff; G Raposo; J Garin; R Sadoul
Journal:  Mol Cell Neurosci       Date:  2006-01-30       Impact factor: 4.314

5.  The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.

Authors:  J L Price; P B Davis; J C Morris; D L White
Journal:  Neurobiol Aging       Date:  1991 Jul-Aug       Impact factor: 4.673

6.  Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils.

Authors:  Aneta T Petkova; Richard D Leapman; Zhihong Guo; Wai-Ming Yau; Mark P Mattson; Robert Tycko
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

7.  Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy.

Authors:  R A Bessen; R F Marsh
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Tau suppression in a neurodegenerative mouse model improves memory function.

Authors:  K Santacruz; J Lewis; T Spires; J Paulson; L Kotilinek; M Ingelsson; A Guimaraes; M DeTure; M Ramsden; E McGowan; C Forster; M Yue; J Orne; C Janus; A Mariash; M Kuskowski; B Hyman; M Hutton; K H Ashe
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

9.  The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system.

Authors:  Hwan-Ching Tai; Alberto Serrano-Pozo; Tadafumi Hashimoto; Matthew P Frosch; Tara L Spires-Jones; Bradley T Hyman
Journal:  Am J Pathol       Date:  2012-08-04       Impact factor: 4.307

10.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Authors:  B T Hyman; G W Van Hoesen; A R Damasio; C L Barnes
Journal:  Science       Date:  1984-09-14       Impact factor: 47.728

View more
  97 in total

Review 1.  Tau immunotherapy and imaging.

Authors:  Einar M Sigurdsson
Journal:  Neurodegener Dis       Date:  2013-09-11       Impact factor: 2.977

2.  Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases.

Authors:  Steven E Arnold; Jon B Toledo; Dina H Appleby; Sharon X Xie; Li-San Wang; Young Baek; David A Wolk; Edward B Lee; Bruce L Miller; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Comp Neurol       Date:  2013-12-15       Impact factor: 3.215

3.  In vivo characterization of the early states of the amyloid-beta network.

Authors:  Jorge Sepulcre; Mert R Sabuncu; Alex Becker; Reisa Sperling; Keith A Johnson
Journal:  Brain       Date:  2013-07       Impact factor: 13.501

Review 4.  Age-related neurodegenerative diseases.

Authors:  Michael Duggan; Bahareh Torkzaban; Taha Mohseni Ahooyi; Kamel Khalili; Jennifer Gordon
Journal:  J Cell Physiol       Date:  2019-09-25       Impact factor: 6.384

5.  Brain banks still yield high interest rates.

Authors:  Dieter Edbauer; Thomas Arzberger
Journal:  J Neural Transm (Vienna)       Date:  2015-07       Impact factor: 3.575

6.  Intranetwork and internetwork connectivity in patients with Alzheimer disease and the association with cerebrospinal fluid biomarker levels.

Authors:  Marina Weiler; Brunno Machado de Campos; Camila Vieira de Ligo Teixeira; Raphael Fernandes Casseb; Ana Flávia Mac Knight Carletti-Cassani; Jéssica Elias Vicentini; Thamires Naela Cardoso Magalhães; Leda Leme Talib; Orestes Vicente Forlenza; Marcio Luiz Figueredo Balthazar
Journal:  J Psychiatry Neurosci       Date:  2017-11       Impact factor: 6.186

7.  Brain structural alterations are distributed following functional, anatomic and genetic connectivity.

Authors:  Franco Cauda; Andrea Nani; Jordi Manuello; Enrico Premi; Sara Palermo; Karina Tatu; Sergio Duca; Peter T Fox; Tommaso Costa
Journal:  Brain       Date:  2018-11-01       Impact factor: 13.501

8.  Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity.

Authors:  Cliona Stack; Shari Jainuddin; Ceyhan Elipenahli; Meri Gerges; Natalia Starkova; Anatoly A Starkov; Mariona Jové; Manuel Portero-Otin; Nathalie Launay; Aurora Pujol; Navneet Ammal Kaidery; Bobby Thomas; Davide Tampellini; M Flint Beal; Magali Dumont
Journal:  Hum Mol Genet       Date:  2014-02-20       Impact factor: 6.150

9.  Treatment of Alzheimer's Disease: Current Management and Experimental Therapeutics.

Authors:  Lawrence S Honig; Clara D Boyd
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2013-09

10.  Prion Protein-Antibody Complexes Characterized by Chromatography-Coupled Small-Angle X-Ray Scattering.

Authors:  Lester Carter; Seung Joong Kim; Dina Schneidman-Duhovny; Jan Stöhr; Guillaume Poncet-Montange; Thomas M Weiss; Hiro Tsuruta; Stanley B Prusiner; Andrej Sali
Journal:  Biophys J       Date:  2015-08-18       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.